ANDA 76823, held by Able. Lithium Carbonate.
As of Nov 15, 2026, ANDA 76823 (Lithium Carbonate), held by Able, was first approved by FDA on Jun 29, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 2004 | Original application | Approved | None posted |
| Lithium Carbonate150MG · capsule;oral | Lithium Carbonate | Discontinued |
| Lithium Carbonate300MG · capsule;oral | Lithium Carbonate | Discontinued |
| Lithium Carbonate600MG · capsule;oral | Lithium Carbonate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
